Log in to save to my catalogue

Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis

Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87b2dd02990d40518d910bef1d5c3eeb

Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis

About this item

Full title

Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis

Publisher

England: BioMed Central Ltd

Journal title

Journal of translational medicine, 2023-12, Vol.21 (1), p.883-17, Article 883

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Sepsis-caused multi-organ failure remains the major cause of morbidity and mortality in intensive care units with limited therapeutics. Nicotinamide mononucleotide (NMN), a precursor of nicotinamide adenine dinucleotide (NAD
), has been recently reported to be protective in sepsis; however, its therapeutic effects remain to be determined. This s...

Alternative Titles

Full title

Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_87b2dd02990d40518d910bef1d5c3eeb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87b2dd02990d40518d910bef1d5c3eeb

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-023-04767-3

How to access this item